FREEDOM-1 clinical trial - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record

Representative image of a large-scale copper mining operation in Chile, reflecting investor focus on Antofagasta PLC shares, Q1 2026 production stability, and the Centinela Second Concentrator growth story.

Antofagasta (LSE: ANTO) surges 5% as Q1 output beats consensus and Centinela build holds schedule

Shubman Gill’s 86 steers Gujarat Titans past Kolkata Knight Riders in IPL 2026

Kizik debuts Freedom Run, betting step-in technology can break into performance running

Kizik launches Freedom Run as it pushes hands-free footwear into the performance running market

Read More

Pharma Industry News

Talaris initiates FREEDOM-1 clinical trial for FCR001 in LDKT recipients

Talaris Therapeutics has initiated the phase 3 FREEDOM-1 clinical trial to evaluate its investigational, allogeneic cell therapy FCR001…

bypharmanewsdaily

October 24, 2019

web analytics